Review of Hyperkalemia Profile for Mineralocorticoid Receptor Antagonist in Patients with Chronic Kidney Disease and Type 2 Diabetes [0.03%]
回顾性分析肾病及糖尿病患者使用盐皮质激素受体拮抗剂的高钾血症谱系风险
Jessica B Kendrick,Angelina Magreni Dixon
Jessica B Kendrick
Background: Type 2 diabetes (T2D) frequently coexists with chronic kidney disease (CKD), magnifying the risk of both cardiovascular and renal complications. Although therapies targeting the renin-angiotensin-aldosterone s...
Integrated Ultrasound Approach to Fluid Assessment and Nutritional Status in Hemodialysis [0.03%]
用于血液透析患者的综合超声评估体液状态和营养状况的方法
Jose C De La Flor,Avinash Chandu Nanwani,Celia Rodríguez Tudero et al.
Jose C De La Flor et al.
Background and aims: Fluid overload is a major determinant of morbidity and mortality in maintenance hemodialysis (MHD) patients. This exploratory study describes the integration of lung ultrasound (LUS), modified Venous ...
Association of Persistent Organic Pollutants Polychlorinated Biphenyls and Dioxins with Cardiovascular-Kidney-Metabolic Syndrome and Its Prognosis: A Nationally Representative Study [0.03%]
多氯联苯和二恶英等持久性有机污染物与心血管-肾脏-代谢综合征及其预后的关联：一项全国性队列研究
Wen Chen,Debin Chen,Yining Li et al.
Wen Chen et al.
Background: Persistent organic pollutants (POPs) may be risk factors for the development and progression of cardiovascular-kidney-metabolic (CKM) syndrome. This study aimed to evaluate the effects of polychlorinated biphe...
Kidney Transplant outcomes in patients with and without type 2 diabetes mellitus [0.03%]
糖尿病患者和非糖尿病患者的肾脏移植预后
Jan H N Lindeman,Rutger J Ploeg,Edward Sharples et al.
Jan H N Lindeman et al.
Introduction: This study aims to estimate the impact of type-II diabetes (DM-II) on kidney transplant outcomes and graft utility. Methods: ...
Intra-dialytic Hypotension and the VExUS Assessment in Hospitalized Patients: A Prospective Cohort Study [0.03%]
住院患者的透析期间低血压与VExUS评估：一项前瞻性队列研究
Rose Joyal,Josiane Proulx,Michel Gouin et al.
Rose Joyal et al.
Introduction: Predicting tolerance to fluid removal is particularly challenging in hospitalized, acutely ill patients. This study evaluated the association between the Venous Excess Ultrasound (VExUS) and IDHE in hospital...
Albuminuria and acute heart failure. A new biomarker for congestion and follow-up? [0.03%]
尿蛋白与急性心力衰竭。评估充血和预后的新型生物标志物？
Mario Galván-Ruiz,Patricia Nogueira-Salgueiro,Belén Rojas-Escrivá et al.
Mario Galván-Ruiz et al.
Introduction: This study evaluated the trajectory of the urine albumin-to-creatinine ratio (UACR) in patients hospitalized with acute Heart Failure (HF) from pre-admission (baseline), through hospital admission, discharge...
Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study [0.03%]
成功活体供肾移植后的功能性二尖瓣反流：VINTAGE研究
Sumi Hidaka,Mizuki Yamano,Yasuhiro Mochida et al.
Sumi Hidaka et al.
Introduction Functional mitral regurgitation (FMR) is prevalent in CKD patients, but few studies have evaluated the effect of kidney transplant (KT) on FMR. This study aimed to clarify KT's effect on FMR. Methods This study included 115 liv...
Amir Kazory,Claudio Ronco
Amir Kazory
Comparative Effectiveness of Ivabradine Versus Digoxin in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort Study [0.03%]
伊伐布雷定与地高辛治疗射血分数降低型心力衰竭合并慢性肾脏病患者的疗效比较：一项真实世界多中心队列研究
Jheng-Yan Wu,Keng-Wei Lee,Sheng-Chi Huang et al.
Jheng-Yan Wu et al.
Background: Heart failure with reduced ejection fraction (HFrEF) commonly coexists with chronic kidney disease (CKD), conferring a markedly increased risk of adverse outcomes. Ivabradine and digoxin are both used for hear...
The relationship between sarcopenia and all-cause and cardiovascular mortality risk among middle-aged and older adults across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from NHANES and CHARLS [0.03%]
基于NHANES和CHARLS证据的心血管肾脏代谢综合征0~3期中老年人群 sarcopenia与全因及心血管死亡风险的关系研究
Yan Chen,Yujun Liu,Shiqi Liu et al.
Yan Chen et al.
Background: Sarcopenia has been proved to be associated with cardiovascular diseases, chronic kidney disease, and metabolic disorders, but the relationship between sarcopenia and all-cause and cardiovascular mortality ris...